Delivery Order SPE2DB20D1100-SPE2DB25FE0ME
Award Date 9/18/25
Potential Completion Date 9/19/25
Potential Value $41K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $41,605.34 delivery order to AmerisourceBergen Drug Corp for the supply of 100 mg vials of Activase, a thrombolytic medication used in acute medical emergencies. The contract, which became effective on September 15, 2025, with completion targeted for September 16, 2025, utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at...
- The Defense Logistics Agency awarded a $32,260.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 50 mg vials of Activase, a thrombolytic medication used for treating acute myocardial infarction and other thromboembolic conditions. The contract, issued on September 19, 2025, with an ultimate completion date of September 22, 2025, represents a non-competitive, non-set-aside procurement. Performance will be executed from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,735.28 to AmerisourceBergen Drug Corp for the supply of Activase 100 mg vials, a thrombolytic medication used in emergency medical treatment. This competitively awarded, firm fixed-price delivery order was executed on October 16, 2025, with an ultimate completion date of October 17, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation,...
- The Defense Logistics Agency awarded a $36,187.73 delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Activase, a thrombolytic medication used in acute medical treatment. This competitively awarded, firm fixed-price contract was issued on September 9, 2025, with an ultimate completion date of September 10, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $17,019.04 to AmerisourceBergen Drug Corp for 50 mg vials of Activase, a thrombolytic medication used in acute medical emergencies. This firm fixed price contract, awarded on June 18, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order carries an ultimate...
- The Defense Logistics Agency awarded a $29,595.40 delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Activase, a thrombolytic medication used to treat acute myocardial infarction and other thrombotic conditions. The contract, issued as a firm fixed price delivery order on September 18, 2025, with completion targeted for September 19, 2025, represents a competitively awarded procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a $11,854.88 delivery order to AmerisourceBergen Drug Corp for the supply of 50 mg vials of Activase, a tissue plasminogen activator used for thrombolytic therapy in acute medical emergencies. This firm fixed-price delivery order, issued on December 6, 2024, with an ultimate completion date of December 9, 2024, was competitively awarded without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Activase 50 mg vials, a thrombolytic medication used in acute medical emergencies. This firm fixed-price delivery order, valued at $3,563.99, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00 through December 2026. The contract was...
- The Defense Logistics Agency awarded a $11.87K delivery order to AmerisourceBergen Drug Corp for 50 mg vials of Activase, a thrombolytic medication used in emergency medical treatment. This competitively awarded, firm fixed-price delivery order was executed on May 30, 2025, with a completion deadline of June 2, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was utilized for this procurement. This delivery order represents a task...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Activase 50 mg vials, valued at $9,340.07, with a firm fixed price and an ultimate completion date of June 3, 2025. This competitively awarded, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. The product will be performed at...